Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial.

These differences may be significant if assuming that the presence of total antibodies is protective against an infection, as suggested for other respiratory viruses ( Polack et al., 2003 ; Polack et al., 2002 ; Winarski et al., 2019 ).

also in 13,097 other papers